Unigestion Holding SA boosted its position in UnitedHealth Group Incorporated (NYSE: UNH – Get Rating) by 102.1% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 9,671 shares of the healthcare conglomerate’s stock after buying an additional 4,885 shares during the quarter. Unigestion Holding SA’s holdings in UnitedHealth Group were worth $ 4,932,000 at the end of the most recent quarter.
A number of other institutional investors have also recently made changes to their positions in the stock. Norges Bank acquired a new position in UnitedHealth Group in the fourth quarter valued at approximately $ 4,478,185,000. State Street Corp boosted its stake in UnitedHealth Group by 1.9% in the fourth quarter. State Street Corp now owns 45,559,868 shares of the healthcare conglomerate’s stock valued at $ 22,877,432,000 after acquiring an additional 869,827 shares during the period. Marshall Wace LLP boosted its stake in UnitedHealth Group by 2,853.0% in the fourth quarter. Marshall Wace LLP now owns 861,798 shares of the healthcare conglomerate’s stock valued at $ 432,746,000 after acquiring an additional 832,614 shares during the period. Capital International Investors boosted its stake in UnitedHealth Group by 4.3% in the fourth quarter. Capital International Investors now owns 19,342,468 shares of the healthcare conglomerate’s stock valued at $ 9,713,058,000 after acquiring an additional 790,219 shares during the period. Finally, Allspring Global Investments Holdings LLC acquired a new position in UnitedHealth Group in the fourth quarter valued at approximately $ 346,859,000. 87.48% of the stock is owned by hedge funds and other institutional investors.
Several equities analysts have recently issued reports on UNH shares. BMO Capital Markets boosted their price target on UnitedHealth Group from $ 510.00 to $ 600.00 and gave the stock a “market perform” rating in a research report on Tuesday, April 19th. StockNews.com started coverage on UnitedHealth Group in a research report on Thursday, March 31st. They set a “strong-buy” rating for the company. Deutsche Bank Aktiengesellschaft boosted their price objective on UnitedHealth Group from $ 482.00 to $ 549.00 and gave the stock a “buy” rating in a research report on Monday, April 18th. Credit Suisse Group upped their target price on UnitedHealth Group from $ 564.00 to $ 595.00 and gave the stock an “outperform” rating in a research report on Monday, April 18th. Finally, Sanford C. Bernstein downgraded UnitedHealth Group from an “outperform” rating to a “market perform” rating and set a $ 561.00 target price for the company. in a research report on Thursday, May 26th. They noted that the move was a valuation call. Three analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and two have given a strong buy rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $ 555.73.
In other news, Director Richard T. Burke sold 2,500 shares of the company stock in a transaction on Thursday, May 19th. The shares were sold at an average price of $ 478.96, for a total value of $ 1,197,400.00. Following the transaction, the director now directly owns 1,215,000 shares of the company stock, valued at $ 581,936,400. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Frederick William Mcnabb III acquired 89 shares of the firm’s stock in a transaction that occurred on Thursday, May 26th. The stock was acquired at an average price of $ 504.32 per share, with a total value of $ 44,884.48. Following the completion of the acquisition, the director now directly owns 11,259 shares of the company stock, valued at approximately $ 5,678,138.88. The disclosure for this purchase can be found here. Corporate insiders own 0.40% of the company stock.
Shares of NYSE: UNH opened at $ 495.64 on Friday. The company fifty day moving average is $ 495.07 and its two-hundred day moving average is $ 491.35. The company has a quick ratio of 0.78, a current ratio of 0.78 and a debt-to-equity ratio of 0.54. UnitedHealth Group Incorporated has a 12-month low of $ 383.12 and a 12-month high of $ 553.29. The company has a market cap of $ 465.00 billion, a P / E ratio of 27.13, a price-to-earnings-growth ratio of 1.52 and a beta of 0.83.
UnitedHealth Group (NYSE: UNH – Get Rating) last announced its earnings results on Thursday, April 14th. The healthcare conglomerate reported $ 5.49 earnings per share (EPS) for the quarter, beating the consensus estimate of $ 5.40 by $ 0.09. UnitedHealth Group had a net margin of 5.86% and a return on equity of 24.74%. The company had revenue of $ 80.15 billion for the quarter, compared to the consensus estimate of $ 78.77 billion. During the same period in the previous year, the business earned $ 5.31 EPS. The company revenue was up 14.2% on a year-over-year basis. Equities research analysts anticipate that UnitedHealth Group Incorporated will post 21.75 earnings per share for the current year.
The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 28th. Shareholders of record on Monday, June 20th will be paid a dividend of $ 1.65 per share. This is an increase from UnitedHealth Group’s previous quarterly dividend of $ 1.45. This represents a $ 6.60 annualized dividend and a yield of 1.33%. The ex-dividend date of this dividend is Thursday, June 16th. UnitedHealth Group’s payout ratio is 36.12%.
UnitedHealth Group Profile: (Get Rating)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children’s health insurance and health care programs; health and dental benefits; and hospital and clinical services.
Featured Stories:
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE: UNH – Get Rating).
Receive News & Ratings for UnitedHealth Group Daily: – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for UnitedHealth Group and related companies with MarketBeat.com’s FREE daily email newsletter.
.